Kalinauskaitė-Žukauskė, V. 2021. CLINICAL TRIALS HAVE PROVEN THE EFFECTIVENESS OF NINTEDANIB TO TREAT A WIDE RANGE OF FIBROSING INTERSTITIAL LUNG DISEASE. Pulmonology and allergology. 5, 2 (Sep. 2021), 170–175. DOI:https://doi.org/10.37499/PIA.766.